Technical Analysis for BIB - ProShares Ultra Nasdaq Biotechnology

Grade Last Price % Change Price Change
grade F 48.35 -0.88% -0.43
BIB closed down 0.88 percent on Thursday, April 18, 2019, on 1.61 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
4 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical BIB trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Expansion Breakdown Bearish Swing Setup -0.88%
Wide Range Bar Range Expansion -0.88%

Older signals for BIB ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
Exchange Traded Funds Stock Market Index Biotechnology Nasdaq Economy Of New York City Nasdaq 100 Nasdaq Biotechnology Total Return Index
Is BIB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Mar 12 Trump 2020 drug pricing initiatives - part 2
Mar 12 Trump aiming to rein in drug cost with range of proposals
Mar 12 2020 federal healthcare budget maintains focus on cutting drug prices
Mar 12 NCI Director Sharpless to head FDA
Mar 11 FDA seeks $643M funding increase aimed at key initiatives
Mar 7 Trump administration exploring price disclosure requirement for hospitals and doctors
Mar 5 Biotech stocks turn lower after reports of FDA commissioner resigning
Mar 5 FDA Commish Gottlieb quits
Feb 21 U.S. healthcare spending to rise 5.5% per annum over next decade
Jan 23 Jefferies bearish on biotechs, sees 6% near-term downside
See more BIB news...
Indicators
Indicator Value
52 Week High 70.82
52 Week Low 36.05
Average Volume 216,261
200-Day Moving Average 57.0162
50-Day Moving Average 55.1126
20-Day Moving Average 54.4465
10-Day Moving Average 54.4
Average True Range 2.2163
ADX 17.73
+DI 13.0167
-DI 39.3177
Chandelier Exit (Long, 3 ATRs ) 51.9911
Chandelier Exit (Short, 3 ATRs ) 53.3489
Upper Bollinger Band 59.8639
Lower Bollinger Band 49.0291
Percent B (%b) -0.06
BandWidth 19.899902
MACD Line -1.055
MACD Signal Line -0.1706
MACD Histogram -0.8844
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 52.81
Resistance 3 (R3) 52.75 51.21 52.06
Resistance 2 (R2) 51.21 50.08 51.24 51.81
Resistance 1 (R1) 49.78 49.37 49.01 49.84 51.57
Pivot Point 48.24 48.24 47.86 48.27 48.24
Support 1 (S1) 46.81 47.11 46.04 46.87 45.13
Support 2 (S2) 45.27 46.40 45.30 44.89
Support 3 (S3) 43.84 45.27 44.64
Support 4 (S4) 43.90